{{Rsnum
|rsid=2278236
|Gene=ANGPTL4
|Chromosome=19
|position=8366697
|Orientation=minus
|GMAF=0.4096
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ANGPTL4
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 15.0 | 52.2 | 32.7
| HCB | 83.2 | 16.8 | 0.0
| JPT | 77.0 | 21.2 | 1.8
| YRI | 19.7 | 46.9 | 33.3
| ASW | 19.3 | 66.7 | 14.0
| CHB | 83.2 | 16.8 | 0.0
| CHD | 87.2 | 12.8 | 0.0
| GIH | 25.7 | 47.5 | 26.7
| LWK | 9.1 | 56.4 | 34.5
| MEX | 24.1 | 53.4 | 22.4
| MKK | 18.6 | 42.3 | 39.1
| TSI | 27.5 | 41.2 | 31.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=21212665
|Title=Angiopoietin-Like 4 (ANGPTL4) Gene Polymorphisms and Risk of Brain Arteriovenous Malformations
|OA=1
}}

{{PMID|18442626}} Genetic variation within the ANGPTL4 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}